Lv11
70 积分 2025-11-16 加入
First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma
24天前
已完结
First-line Therapy for Advanced Non–Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysis
24天前
已关闭
Re: First-line Therapy for Advanced Non–Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysis
24天前
已关闭
TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study
1个月前
已关闭
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma
1个月前
已完结
Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
1个月前
已完结
Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis
1个月前
已完结
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis
1个月前
已完结
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
1个月前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
1个月前
已完结
Expression of miR-155 in Serum Exosomes in Children with Epilepsy and Its Diagnostic Value
皖公网安备34019202002308
